LYNN MCINNIS: Open Payments
NPI 1417130279 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 33 payments from 16 companies in 2025. Trend: 2023 $904 · 2024 $917 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $196 |
| PFIZER INC. | 3 | $77 |
| Novo Nordisk Inc | 4 | $76 |
| Lilly USA, LLC | 3 | $57 |
| Seqirus USA Inc | 3 | $54 |
| Amgen Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| ABBVIE INC. | 2 | $29 |
Products named: BREZTRI, JARDIANCE, FARXIGA, PREVNAR 20, Veozah, INSPIRE, Wegovy, OTEZLA.
Industry payments across TX — which companies pay providers there.
